Asset

Abacavir Sulfate

Viatris Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (3)

ApplicationTypeApplicant
ANDA 090309ANDAMYLAN PHARMA
ANDA 091294ANDAMYLAN PHARMACEUTICALS INC
NDA 202381NDAMYLAN LABS

Marketed products (3)

  • ABACAVIR SULFATE
  • ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
  • ABACAVIR SULFATE; LAMIVUDINE